Trends in national pharmaceutical expenditure on diabetes in Ireland 2011-2015: a repeated cross-sectional study.

ABSTRACT:

Objectives

To explore trends in pharmaceutical expenditure on diabetes between 2011 and 2015, describing trends in expenditure on blood glucose-lowering medications and estimating the effect of cost-containment measures implemented during this time.

Design

Repeated cross-sectional study of national pharmacy claims data in Ireland.

Participants

Patients' dispensed items used in the treatment or management of diabetes.

Primary and secondary outcomes

Total expenditure associated with diabetes was calculated by extracting data on all diabetes-related items dispensed to eligible patients. Costs were categorised into two groups. Diabetes-specific items include items used directly in diabetes treatment (WHO-Anatomical Therapeutic Chemical (ATC): A10, V07, V04) and dia

SUBMITTER: O Neill KN 

PROVIDER: S-EPMC7552837 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature